BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37632352)

  • 21. Circular RNA hsa_circ_0077837 is upregulated in non-small cell lung cancer to downregulate phosphatase and tensin homolog through methylation.
    Li D; Lv H; Gao H; Wang Z; Wang D; Tian K; Li L
    Bioengineered; 2022 Mar; 13(3):6711-6718. PubMed ID: 35246018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircBRIP1: a plasma diagnostic marker for non-small-cell lung cancer.
    Fan X; Zhang Q; Qin S; Ju S
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):83. PubMed ID: 38329551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis.
    Jiang MM; Mai ZT; Wan SZ; Chi YM; Zhang X; Sun BH; Di QG
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):667-674. PubMed ID: 29372377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value.
    Yao JT; Zhao SH; Liu QP; Lv MQ; Zhou DX; Liao ZJ; Nan KJ
    Pathol Res Pract; 2017 May; 213(5):453-456. PubMed ID: 28343871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HSA_CIRC_0004050 on proliferation and apoptosis of A549 cells through ERK/JNK signaling pathway.
    Wang Y; Zang RK; Du YN
    J Biol Regul Homeost Agents; 2020; 34(6):2037-2047. PubMed ID: 33348975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. hsa_circ_0003176 Suppresses the Progression of Non-Small-Cell Lung Cancer via Regulating miR-182-5p/RBM5 Axis.
    Yang F; Pei Y; Xu W; Rong L
    Dis Markers; 2022; 2022():8402116. PubMed ID: 36193508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling.
    Ge P; Chen X; Liu J; Jing R; Zhang X; Li H
    Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.
    Zhang X; Tan J; Chen Y; Ma S; Bai W; Peng Y; Shi G
    BMC Pulm Med; 2022 Dec; 22(1):479. PubMed ID: 36522766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircFOXP1: A novel serum diagnostic biomarker for non-small cell lung cancer.
    Luo Y; Zhang Q; Lv B; Shang Y; Li J; Yang L; Yu Z; Luo K; Deng X; Min L; Zhu T
    Int J Biol Markers; 2022 Mar; 37(1):58-65. PubMed ID: 35072545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
    Wang H; Wang J; Liang CF; Zhou T
    Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of circular RNA expression profiles of lung cancer in Xuanwei, China.
    Wang Y; Lu LJ; Duan Y; Liu X; Mao Y; Chen Y; Zhang YL
    J Clin Lab Anal; 2020 Dec; 34(12):e23521. PubMed ID: 32844469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic performance of lysine(K)-specific demethylase 6B (
    Ge T; Zhou Y; Lu H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2155-2160. PubMed ID: 31155967
    [No Abstract]   [Full Text] [Related]  

  • 33. Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection.
    Yin WB; Yan MG; Fang X; Guo JJ; Xiong W; Zhang RP
    Clin Chim Acta; 2018 Dec; 487():363-368. PubMed ID: 29045858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of a circular RNA-microRNA-messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysis.
    Li Y; Shi R; Zhu G; Chen C; Huang H; Gao M; Xu S; Cao P; Zhang Z; Wu D; Li X; Liu H; Chen J
    Thorac Cancer; 2022 Jan; 13(1):61-75. PubMed ID: 34806315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
    Li W; Li N; Kang X; Shi K
    Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Key circRNAs in Non-Small Cell Lung Cancer.
    Li L; Sun D; Li X; Yang B; Zhang W
    Am J Med Sci; 2021 Jan; 361(1):98-105. PubMed ID: 32962802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Hsa_circ_0005962 Is A Prognostic Biomarker of Paclitaxel Resistance in Nonsmall Cell Lung Cancer Treatment.
    Wang C; Xia S
    Int J Clin Pract; 2023; 2023():6644168. PubMed ID: 37901849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircRNA hsa_circ_0070659 predicts poor prognosis and promotes non-small cell lung cancer (NSCLC) progression via microRNA-377 (miR-377) / Ras-Associated Binding Protein 3C (RAB3C) pathway.
    Meng Q; Li Y; Sun Z; Yang X
    Bioengineered; 2022 Jun; 13(6):14578-14594. PubMed ID: 36694911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular RNA hsa_circ_0072309 inhibits non-small cell lung cancer progression by sponging miR-580-3p.
    Pang W; Huang F; Zhang X; Ye M; Huang Y; Huang X; Pang J; Cai C; Wang Z
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32293004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer.
    Min L; Zhu T; Lv B; An T; Zhang Q; Shang Y; Yu Z; Zheng L; Wang Q
    Int J Clin Oncol; 2022 Jun; 27(6):1013-1024. PubMed ID: 35482171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.